Tara James, Chair of the Board of Directors of Fighting Blindness Canada, is delighted to announce the appointment of Jennifer Jones as the new President and Chief Executive Officer (CEO) effective May…
Read More
From April 23-27, Fighting Blindness Canada attended one of the largest vision research conferences in the world: the Association for Research in Vision and Ophthalmology (ARVO). It was illuminating to learn about…
Read More
Matthew is at least the fourth generation in his family to be affected by retinitis pigmentosa (RP), a rare genetic eye disease that over time makes cells in the retina break down,…
Read More
May Vision Health Month is a time when Canadians bring awareness to eye health and the prevention of vision loss. Throughout the month of May, we will be highlighting our mission of…
Read More
Fighting Blindness Canada would like to share that on June 2, 2023, Ann Morrison, Director of Philanthropy, will be retiring. We are happy for Ann to start this next chapter of her…
Read More
Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by…
Read MoreJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
